Jane Street Group, LLC Re Shape Lifesciences Inc. Transaction History

Jane Street Group, LLC

  • $72.9 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$0.32 - $0.6 $16,697 - $31,308
52,180 New
52,180 $16,000
Q3 2022

Nov 14, 2022
BUY
$0.32 - $0.6 $16,697 - $31,308
52,180 New
52,180 $16,000
Q3 2021

Nov 16, 2021
SELL
$2.67 - $5.09 $64,581 - $123,116
-24,188 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$2.02 - $7.64 $48,859 - $184,796
24,188 New
24,188 $121,000

About ReShape Lifesciences Inc.

RSLS Quotes by TradingView
  • Ticker RSLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 22,559,400
  • Market Cap $4.74M
  • Description
  • ReShape Lifesciences Inc., a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical sta...
More about RSLS
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email